Literature DB >> 14739571

Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studies.

Paolo Ragonese1, Graziella Filippini, Giuseppe Salemi, Ettore Beghi, Antonietta Citterio, Roberto D'Alessandro, Carmine Marini, Maria Rosaria Monsurrò, Isidoro Aiello, Letterio Morgante, Antonella Tempestini, Cesare Fratti, Michele Ragno, Maura Pugliatti, Antonio Epifanio, Daniela Testa, Giovanni Savettieri.   

Abstract

OBJECTIVE: To evaluate the accuracy of death certificates (DCs) for amyotrophic lateral sclerosis (ALS) in different parts of Italy. Studies based on DC diagnosis for ALS have shown a reduced mortality comparing northern with southern Italy. These data are in contrast with results from other surveys on the incidence of ALS performed in Italy and other countries.
METHODS: Archives of neurological clinics from northern (Milano, Monza, Pavia, and Bologna) and southern Italy including islands (Napoli, Sassari, Palermo, and Messina) were searched for patients discharged with a diagnosis of ALS in the period 1970-1995. Subjects affected by definite/probable ALS according to the Scottish Motor Neuron Disease Research Group diagnostic criteria were included. DCs were obtained from the vital statistic bureau. True positive rates (TPRs) and 95% confidence intervals (CIs) for proportions were calculated for northern and southern Italy separately. Multiple logistic regression analysis was performed according to gender, age at onset, age and year of death, and interval between onset and death.
RESULTS: We found 651 patients affected by definite/probable ALS; 573 of them had died by December 31, 1996. DCs were available for 566 subjects (411 from northern Italy and 155 from southern Italy). TPR was 66.7% (95% CI 61.9-71.2) for northern Italy and 51.6% (95% CI 43.5-59.7) for southern Italy (chi(2) = 10.9, p = 0.001). Logistic regression analysis showed an association between a lower accuracy of DCs and the interval between onset of symptoms and death. TPR calculations considering different death periods (1970-1982 and 1983-1996) showed comparable rates of accuracy over time.
CONCLUSIONS: Mortality statistics based on official death records do not accurately reflect interregional mortality for ALS in Italy. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 14739571     DOI: 10.1159/000073978

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  9 in total

Review 1.  Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials.

Authors:  Paul H Gordon
Journal:  Aging Dis       Date:  2013-10-01       Impact factor: 6.745

2.  Changing mortality for motor neuron disease in France (1968-2007): an age-period-cohort analysis.

Authors:  Paul H Gordon; Fanny Artaud; Albertine Aouba; Françoise Laurent; Vincent Meininger; Alexis Elbaz
Journal:  Eur J Epidemiol       Date:  2011-06-15       Impact factor: 8.082

3.  Validating population-based registers for ALS: how accurate is death certification?

Authors:  Loraine Yeo; Catherine Lynch; Orla Hardiman
Journal:  J Neurol       Date:  2010-02-12       Impact factor: 4.849

Review 4.  A systematic review on the risk of neurodegenerative diseases and neurocognitive disorders in professional and varsity athletes.

Authors:  G Bellomo; P Piscopo; M Corbo; E Pupillo; G Stipa; E Beghi; N Vanacore; E Lacorte
Journal:  Neurol Sci       Date:  2022-08-17       Impact factor: 3.830

5.  Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data.

Authors:  Raffaella Uccelli; Alessandra Binazzi; Pierluigi Altavista; Stefano Belli; Pietro Comba; Marina Mastrantonio; Nicola Vanacore
Journal:  Eur J Epidemiol       Date:  2007-09-14       Impact factor: 8.082

6.  Encephalitis-associated hospitalizations among American Indians and Alaska Natives.

Authors:  Jason M Mehal; Robert C Holman; Neil M Vora; Jesse Blanton; Paul H Gordon; James E Cheek
Journal:  Am J Trop Med Hyg       Date:  2014-02-10       Impact factor: 2.345

7.  Survival and Cause of Death among a Cohort of Confirmed Amyotrophic Lateral Sclerosis Cases.

Authors:  Susan T Paulukonis; Eric M Roberts; Jhaqueline P Valle; Natalie N Collins; Paul B English; Wendy E Kaye
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

8.  Association of lead exposure with survival in amyotrophic lateral sclerosis.

Authors:  Freya Kamel; David M Umbach; Lillian Stallone; Marie Richards; Howard Hu; Dale P Sandler
Journal:  Environ Health Perspect       Date:  2008-07       Impact factor: 9.031

9.  Analysis of incidence of motor neuron disease in England 1998-2019: use of three linked datasets.

Authors:  Judith M Burchardt; Xue W Mei; Tom Ranger; Christopher J McDermott; Aleksandar Radunovic; Carol Coupland; Julia Hippisley-Cox
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2022-02-01       Impact factor: 3.528

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.